Index
A
Activation energy, 68, 69, 130, 134, 137,
138, 141, 143, 146, 191
Active pharmaceutical ingredients, 55, 56
Adam and Gibbs, 55, 70
Alcohol, 95
α-relaxation time, 24, 27, 28, 31, 32, 36, 44,
155, 195, 197, 198, 200, 201, 203,
204, 206, 208, 210, 214, 217, 218
Aluminum oxide (Al 2 O 3 ), 244, 250, 256
Amorphous pharmaceutical, 55, 72
Aripiprazol (ARP), 55, 83
Avrami, 24, 32, 40, 44, 49, 64–69, 90, 101,
130–132, 134, 136, 141–146, 232,
233, 272, 278, 280
B
Barium titanate (BaTiO 3 ), 244, 262
Bicalutamide (BIC), 55, 84
Biopharmaceutics classification system
(BCS), 55–57
C
Calcium carbonate (CaCO 3 ), 244, 261
Calorimetry, 18, 30, 119, 139, 170, 173, 200,
271
Carbon nanofibers (CNF), 244, 257–259
CDT diagram, 24, 38
Chiral nematic, 120
CHT diagram, 24, 38, 39
Cole-Cole, 170, 173, 178, 202
Confined amorphous fraction (CAF), 268,
275–277, 280, 283, 284
Confinement, 143, 171, 172, 189, 191, 208,
216, 221, 223, 224–227, 231, 268,
269, 275, 284
Conformationally disordered crystals, 120
Critical cluster, 2–4, 9, 14, 15
Crystal growth, 1, 9, 11, 26–30, 34, 35, 45,
74, 91, 101, 108, 109, 111, 112, 115,
133, 136, 140, 146, 150, 151, 153,
155, 157, 159–161, 221, 222, 225,
233, 234
Crystallinity, 26, 32, 42, 49, 59, 96–98, 122,
131, 140–143, 146, 160, 175, 198,
202, 204, 205, 208, 209, 215, 218,
227, 243, 244, 246–249, 252, 254,
271, 272, 274, 277, 281, 283
Crystallization, v, 1–18, 23–51, 55, 57–60,
62–70, 72–75, 78, 79, 81, 84, 89,
90, 92, 93, 96–99, 101, 102, 104–
108, 110–114, 119–121, 124, 129–
146, 149–153, 155–162, 164–166,
169–177, 180–192, 195, 197, 198,
200–207, 209, 210, 213, 215–218,
221–223, 225–230, 232–238, 249,
268–272, 274–276, 279–284
Crystallization half-time, 24
Crystallization time, 114, 222, 228
Crystal polymorphs, 149
D
Decoupling, 1, 11, 13, 133
Dielectric breakdown strength, 243, 254–
256, 259, 261–263
Dielectric probes, 243, 251, 263
Differential scanning calorimetry (DSC), 56,
76, 79, 119, 120, 122–125, 135, 136,
© Springer Nature Switzerland AG 2020
T. A. Ezquerra and A. Nogales (eds.), Crystallization as Studied
by Broadband Dielectric Spectroscopy, Advances in Dielectrics,
https://doi.org/10.1007/978-3-030-56186-4
287
A
Activation energy, 68, 69, 130, 134, 137,
138, 141, 143, 146, 191
Active pharmaceutical ingredients, 55, 56
Adam and Gibbs, 55, 70
Alcohol, 95
α-relaxation time, 24, 27, 28, 31, 32, 36, 44,
155, 195, 197, 198, 200, 201, 203,
204, 206, 208, 210, 214, 217, 218
Aluminum oxide (Al 2 O 3 ), 244, 250, 256
Amorphous pharmaceutical, 55, 72
Aripiprazol (ARP), 55, 83
Avrami, 24, 32, 40, 44, 49, 64–69, 90, 101,
130–132, 134, 136, 141–146, 232,
233, 272, 278, 280
B
Barium titanate (BaTiO 3 ), 244, 262
Bicalutamide (BIC), 55, 84
Biopharmaceutics classification system
(BCS), 55–57
C
Calcium carbonate (CaCO 3 ), 244, 261
Calorimetry, 18, 30, 119, 139, 170, 173, 200,
271
Carbon nanofibers (CNF), 244, 257–259
CDT diagram, 24, 38
Chiral nematic, 120
CHT diagram, 24, 38, 39
Cole-Cole, 170, 173, 178, 202
Confined amorphous fraction (CAF), 268,
275–277, 280, 283, 284
Confinement, 143, 171, 172, 189, 191, 208,
216, 221, 223, 224–227, 231, 268,
269, 275, 284
Conformationally disordered crystals, 120
Critical cluster, 2–4, 9, 14, 15
Crystal growth, 1, 9, 11, 26–30, 34, 35, 45,
74, 91, 101, 108, 109, 111, 112, 115,
133, 136, 140, 146, 150, 151, 153,
155, 157, 159–161, 221, 222, 225,
233, 234
Crystallinity, 26, 32, 42, 49, 59, 96–98, 122,
131, 140–143, 146, 160, 175, 198,
202, 204, 205, 208, 209, 215, 218,
227, 243, 244, 246–249, 252, 254,
271, 272, 274, 277, 281, 283
Crystallization, v, 1–18, 23–51, 55, 57–60,
62–70, 72–75, 78, 79, 81, 84, 89,
90, 92, 93, 96–99, 101, 102, 104–
108, 110–114, 119–121, 124, 129–
146, 149–153, 155–162, 164–166,
169–177, 180–192, 195, 197, 198,
200–207, 209, 210, 213, 215–218,
221–223, 225–230, 232–238, 249,
268–272, 274–276, 279–284
Crystallization half-time, 24
Crystallization time, 114, 222, 228
Crystal polymorphs, 149
D
Decoupling, 1, 11, 13, 133
Dielectric breakdown strength, 243, 254–
256, 259, 261–263
Dielectric probes, 243, 251, 263
Differential scanning calorimetry (DSC), 56,
76, 79, 119, 120, 122–125, 135, 136,
© Springer Nature Switzerland AG 2020
T. A. Ezquerra and A. Nogales (eds.), Crystallization as Studied
by Broadband Dielectric Spectroscopy, Advances in Dielectrics,
https://doi.org/10.1007/978-3-030-56186-4
287